Cargando…

Editorial: Intestinal Dysbiosis in Inflammatory Diseases

Detalles Bibliográficos
Autores principales:	de Oliveira, Gislane Lelis Vilela, Cardoso, Cristina Ribeiro de Barros, Taneja, Veena, Fasano, Alessio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362080/ https://www.ncbi.nlm.nih.gov/pubmed/34394133 http://dx.doi.org/10.3389/fimmu.2021.727485

Ejemplares similares

Microbiota Modulation of the Gut-Lung Axis in COVID-19
por: de Oliveira, Gislane Lelis Vilela, et al.
Publicado: (2021)

Intestinal Dysbiosis in Autoimmune Diabetes Is Correlated With Poor Glycemic Control and Increased Interleukin-6: A Pilot Study
por: Higuchi, Bruna Stevanato, et al.
Publicado: (2018)

Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases
por: Marietta, Eric, et al.
Publicado: (2020)

Editorial: Dietary habits, microbiota and autoimmune diseases
por: Pucca, Manuela Berto, et al.
Publicado: (2023)

Editorial: Women in microbiome in health and disease 2021
por: Pereira, Maria de Lourdes, et al.
Publicado: (2022)

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2018)

Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution
por: Ferreira-Junior, Alexandre Soares, et al.
Publicado: (2022)

Editorial: Microbiome in the growth and management of different types of cancer
por: Khan, Abdul Arif, et al.
Publicado: (2023)

Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis
por: Cayres, Leonardo César de Freitas, et al.
Publicado: (2021)

NLR and Intestinal Dysbiosis-Associated Inflammatory Illness: Drivers or Dampers?
por: Elias-Oliveira, Jefferson, et al.
Publicado: (2020)

Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing–Remitting Multiple Sclerosis
por: Pellizoni, Felipe Papa, et al.
Publicado: (2021)

Intestinal Dysbiosis and Autoimmune Pancreatitis
por: Yoshikawa, Tomoe, et al.
Publicado: (2021)

Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity
por: Brown, Josephine, et al.
Publicado: (2020)

Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity
por: Kinashi, Yusuke, et al.
Publicado: (2021)

Association of Intestinal Microbial Dysbiosis With Chronic Obstructive Pulmonary Disease
por: Ananya, Fariha N, et al.
Publicado: (2021)

Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity
por: Honkanen, Jarno, et al.
Publicado: (2020)

Virus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes
por: Morse, Zachary J., et al.
Publicado: (2021)

Detection of Increased Plasma Interleukin-6 Levels and Prevalence of Prevotella copri and Bacteroides vulgatus in the Feces of Type 2 Diabetes Patients
por: Leite, Aline Zazeri, et al.
Publicado: (2017)

Glucose but Not Fructose Alters the Intestinal Paracellular Permeability in Association With Gut Inflammation and Dysbiosis in Mice
por: Zhang, Xufei, et al.
Publicado: (2021)

Pyruvate: Ferredoxin oxidoreductase is involved in IgA-related microbiota dysbiosis and intestinal inflammation
por: Wang, Kairuo, et al.
Publicado: (2022)

Editorial: Regulation of osteoclast differentiation in autoimmune and inflammatory diseases
por: Lee, Sun-Kyeong, et al.
Publicado: (2023)

Functional Fermented Milk with Fruit Pulp Modulates the In Vitro Intestinal Microbiota
por: Borgonovi, Tais Fernanda, et al.
Publicado: (2022)

Gut Dysbiosis Is Associated With the Severity of Cryptogenic Stroke and Enhanced Systemic Inflammatory Response
por: Zheng, Qianyi, et al.
Publicado: (2022)

Intestinal Dysbiosis and the Developing Lung: The Role of Toll-Like Receptor 4 in the Gut-Lung Axis
por: Wedgwood, Stephen, et al.
Publicado: (2020)

Intestinal Dysbiosis Is Associated with Altered Short-Chain Fatty Acids and Serum-Free Fatty Acids in Systemic Lupus Erythematosus
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2017)

Sex Hormones Determine Immune Response
por: Taneja, Veena
Publicado: (2018)

Editorial: Role of Neutrophils in Inflammatory Diseases
por: Marichal, Thomas, et al.
Publicado: (2020)

Editorial: Inflammatory Mechanisms of Hemolytic Diseases
por: Sesti-Costa, Renata, et al.
Publicado: (2022)

Editorial: Microbiota in skin inflammatory diseases
por: Park, Eun Jeong, et al.
Publicado: (2023)

CRTAM Protects Against Intestinal Dysbiosis During Pathogenic Parasitic Infection by Enabling Th17 Maturation
por: Cervantes-Barragan, Luisa, et al.
Publicado: (2019)

Microbial dysbiosis in the gut drives systemic autoimmune diseases
por: Mousa, Walaa K., et al.
Publicado: (2022)

Octanoate Alleviates Dietary Soybean Oil-Induced Intestinal Physical Barrier Damage, Oxidative Stress, Inflammatory Response and Microbial Dysbiosis in Large Yellow Croaker (Larimichthys Crocea)
por: Zhang, Zhou, et al.
Publicado: (2022)

In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines
por: Fiorentino, Maria, et al.
Publicado: (2013)

Intestinal Microbes in Autoimmune and Inflammatory Disease
por: Wu, Wan-Jung H., et al.
Publicado: (2020)

Editorial: Role of matrix metalloproteinases and other inflammatory mediators in the disruption of the intestinal tight junction barrier
por: Al-Sadi, Rana, et al.
Publicado: (2023)

Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
por: Yadav, Sudhir K., et al.
Publicado: (2022)

Manipulation of Salmonella Typhi Gene Expression Impacts Innate Cell Responses in the Human Intestinal Mucosa
por: Salerno-Gonçalves, Rosângela, et al.
Publicado: (2018)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
por: von Knethen, Andreas, et al.
Publicado: (2021)

Editorial: Metabolic conditions of chronic inflammatory diseases
por: Saalbach, Anja, et al.
Publicado: (2022)

Editorial: Targeting signalling pathways in inflammatory diseases
por: Baig, Mirza S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_84pasr4b0906le4n0t9r68hrt8